Related Experiment Video
Updated: Jun 17, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Cerebral microbleeds in predialysis patients with chronic kidney disease
Hideaki Shima1, Eiji Ishimura, Toshihide Naganuma
1Department of Endocrinology, Metabolism and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Background:
Gradient-echo T2*-weighted magnetic resonance imaging (T2*-weighted MRI) is highly sensitive for detecting cerebral microbleeds (CMBs). CMBs have been reported to be a risk factor for future cerebrovascular events and a marker of cerebral small vessel disease in the general population. Chronic kidney disease (CKD) is an independent risk factor for cardiovascular disease. The relationship between CKD and CMBs, which has not been clarified to date, is examined.
Methods:
In this cross-sectional study, T2*-weighted MRI of brain was performed with a 1.5-T MRI system in 162 CKD patients (CKD stages 1-5, excluding CKD stage 5(D)) and 24 normal subjects.
Results:
CMBs were found in 35 CKD patients (25.6%), but not in control subjects. CMBs were more prevalent in male patients, in those with higher blood pressure, advanced age and poor kidney function. There was a significant association between the prevalence of CMBs and the CKD stage, with higher prevalence of CMBs as the CKD stages advanced (P < 0.01). Estimated glomerular filtration rate was a significant factor associated with the prevalence of CMBs, independent of age, gender and hypertension. There was no significant relationship between CMBs and the presence of diabetes mellitus and dyslipidemia.
Conclusions:
Decreased renal function is a significant risk factor for CMBs, independent of the presence of hypertension. Poor kidney function could be associated with future cerebrovascular events.
Insights
Chronic kidney disease (CKD) is linked to cerebral microbleeds (CMBs), detected by T2*-weighted MRI. Poor kidney function, independent of hypertension, increases CMB risk, potentially indicating future cerebrovascular events.
Area of Science:
- Neurology
- Nephrology
- Radiology
Background:
- Cerebral microbleeds (CMBs) are associated with cerebrovascular events and small vessel disease.
- Chronic kidney disease (CKD) is an independent cardiovascular disease risk factor.
- The link between CKD and CMBs requires further investigation.
Purpose of the Study:
- To investigate the relationship between chronic kidney disease (CKD) and cerebral microbleeds (CMBs).
- To determine if decreased renal function is an independent risk factor for CMBs.
Main Methods:
- A cross-sectional study involving 162 CKD patients (stages 1-5, excluding 5(D)) and 24 healthy controls.
- Brain T2*-weighted MRI was performed using a 1.5-T system.
- Patient data included age, gender, blood pressure, diabetes mellitus, dyslipidemia, and estimated glomerular filtration rate.
Main Results:
- CMBs were detected in 25.6% of CKD patients, but not in controls.
- CMB prevalence increased with CKD stage and was higher in males, those with higher blood pressure, and older age.
- Lower estimated glomerular filtration rate was significantly associated with CMB prevalence, independent of other factors.
Conclusions:
- Decreased renal function is a significant risk factor for CMBs, independent of hypertension.
- Poor kidney function may be linked to an increased risk of future cerebrovascular events.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Diabetic Nephropathy
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury II: Pathophysiology

